Literature DB >> 28734829

Feasibility of prophylactic salpingectomy during vaginal hysterectomy.

Danielle D Antosh1, Rachel High2, Heidi W Brown3, Sallie S Oliphant4, Husam Abed5, Nisha Philip6, Cara L Grimes6.   

Abstract

BACKGROUND: The American Congress of Obstetricians and Gynecologists recommends that "the surgeon and patient discuss the potential benefits of the removal of the fallopian tubes during a hysterectomy in women at population risk of ovarian cancer who are not having an oophorectomy," resulting in an increasing rate of salpingectomy at the time of hysterectomy. Rates of salpingectomy are highest for laparoscopic and lowest for vaginal hysterectomy.
OBJECTIVE: The primary objective of this study was to determine the feasibility of bilateral salpingectomy at the time of vaginal hysterectomy. Secondary objectives included identification of factors associated with unsuccessful salpingectomy and assessment of its impact on operating time, blood loss, surgical complications, and menopausal symptoms. STUDY
DESIGN: This was a multicenter, prospective study of patients undergoing planned vaginal hysterectomy with bilateral salpingectomy. Baseline medical data along with operative findings, operative time, and blood loss for salpingectomy were recorded. Uterine weight and pathology reports for all fallopian tubes were reviewed. Patients completed the Menopause Rating Scale at baseline and at postoperative follow-up. Descriptive analyses were performed to characterize the sample and compare those with successful and unsuccessful completion of planned salpingectomy using Student t test, and χ2 test when appropriate. Questionnaire scores were compared using paired t tests.
RESULTS: Among 77 patients offered enrollment, 74 consented (96%), and complete data were available regarding primary outcome for 69 (93%). Mean age was 51 years. Median body mass index was 29.1 kg/m2; median vaginal parity was 2, and 41% were postmenopausal. The indications for hysterectomy included prolapse (78%), heavy menstrual bleeding (20%), and fibroids (11%). When excluding conversions to alternate routes, vaginal salpingectomy was successfully performed in 52/64 (81%) women. Mean operating time for bilateral salpingectomy was 11 (±5.6) minutes, with additional estimated blood loss of 6 (±16.3) mL. There were 8 surgical complications: 3 hemorrhages >500 mL and 5 conversions to alternate routes of surgery, but none of these were due to the salpingectomy. Mean uterine weight was 102 g and there were no malignancies on fallopian tube pathology. Among the 17 patients in whom planned bilateral salpingectomy was not completed, unilateral salpingectomy was performed in 7 patients. Reasons for noncompletion included: tubes high in the pelvis (8), conversion to alternate route for pathology (4), bowel or sidewall adhesions (3), tubes absent (1), and ovarian adhesions (1). Prior adnexal surgery (odds ratio, 2.9; 95% confidence interval, 1.5-5.5; P = .006) and uterine fibroids (odds ratio, 5.8; 95% confidence interval, 1.5-22.5; P = .02) were the only significant factors associated with unsuccessful bilateral salpingectomy. Mean menopause scores improved after successful salpingectomy (12.7 vs 8.6; P < .001).
CONCLUSION: Vaginal salpingectomy is feasible in the majority of women undergoing vaginal hysterectomy and increases operating time by 11 minutes and blood loss by 6 mL. Women with prior adnexal surgery or uterine fibroids should be counseled about the possibility that removal may not be feasible.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  benign; fallopian; hysterectomy; prophylactic; salpingectomy; vaginal

Mesh:

Year:  2017        PMID: 28734829      PMCID: PMC6155463          DOI: 10.1016/j.ajog.2017.07.017

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

1.  ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

Authors:  Fabiola Medeiros; Michael G Muto; Yonghee Lee; Julia A Elvin; Michael J Callahan; Colleen Feltmate; Judy E Garber; Daniel W Cramer; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

4.  Committee opinion no. 620: Salpingectomy for ovarian cancer prevention.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-01       Impact factor: 7.661

Review 5.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

6.  Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.

Authors:  Albert Asante; Maura K Whiteman; Aniket Kulkarni; Shanna Cox; Polly A Marchbanks; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

7.  The place of oophorectomy at vaginal hysterectomy.

Authors:  S S Sheth
Journal:  Br J Obstet Gynaecol       Date:  1991-07

8.  Nationwide trends in the performance of inpatient hysterectomy in the United States.

Authors:  Jason D Wright; Thomas J Herzog; Jennifer Tsui; Cande V Ananth; Sharyn N Lewin; Yu-Shiang Lu; Alfred I Neugut; Dawn L Hershman
Journal:  Obstet Gynecol       Date:  2013-08       Impact factor: 7.661

9.  Increased cardiovascular mortality after early bilateral oophorectomy.

Authors:  Cathleen M Rivera; Brandon R Grossardt; Deborah J Rhodes; Robert D Brown; Véronique L Roger; L Joseph Melton; Walter A Rocca
Journal:  Menopause       Date:  2009 Jan-Feb       Impact factor: 2.953

10.  Nationwide use of laparoscopic hysterectomy compared with abdominal and vaginal approaches.

Authors:  Vanessa L Jacoby; Amy Autry; Gavin Jacobson; Robert Domush; Sanae Nakagawa; Alison Jacoby
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

View more
  5 in total

1.  Adnexectomy at the time of vaginal hysterectomy for pelvic organ prolapse.

Authors:  Emily A Slopnick; David D Sheyn; Graham C Chapman; Sangeeta T Mahajan; Sharif El-Nashar; Adonis K Hijaz
Journal:  Int Urogynecol J       Date:  2019-05-21       Impact factor: 2.894

2.  Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.

Authors:  Laura A M van Lieshout; Miranda P Steenbeek; Joanne A De Hullu; M Caroline Vos; Saskia Houterman; Jack Wilkinson; Jurgen Mj Piek
Journal:  Cochrane Database Syst Rev       Date:  2019-08-28

3.  Prophylactic salpingectomy and ovarian cancer: An evidence-based analysis.

Authors:  Tricia Dewi Anggraeni; Adly Nanda Al Fattah; Raymond Surya
Journal:  South Asian J Cancer       Date:  2018 Jan-Mar

4.  Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey.

Authors:  Miranda P Steenbeek; Laura A M van Lieshout; Johanna W M Aarts; Jurgen M J Piek; Sjors F P J Coppus; Leon F A G Massuger; Rosella P M G Hermens; Joanne A de Hullu
Journal:  J Gynecol Oncol       Date:  2018-04-30       Impact factor: 4.401

5.  Survey: acceptability of opportunistic bilateral salpingectomy in Flanders.

Authors:  A S Maryns; A Makar; T Hamerlynck; B De Vree; P Tummers; W A A Tjalma
Journal:  Facts Views Vis Obgyn       Date:  2021-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.